Advances in immunotherapy for cervical cancer: recent developments and future directions

医学 免疫疗法 宫颈癌 放射治疗 癌症 免疫系统 疾病 癌症免疫疗法 免疫检查点 肿瘤科 免疫学 内科学
作者
Michael V. Sherer,Nikhil V. Kotha,Casey W. Williamson,Jyoti Mayadev
出处
期刊:International Journal of Gynecological Cancer [BMJ]
卷期号:32 (3): 281-287 被引量:43
标识
DOI:10.1136/ijgc-2021-002492
摘要

There is an unmet need for novel therapies to improve clinical outcomes for patients with locally advanced, recurrent, or metastatic cervical cancer. Most cases of cervical cancer are driven by infection with human papillomavirus (HPV), which uses multiple mechanisms to avoid immune surveillance. Several classes of agents have been developed that seek to activate the immune system in order to overcome this resistance and improve treatment outcomes. These include immune checkpoint inhibitors, therapeutic vaccines, engineered T cells, and antibody-drug conjugates. Here, we review the immune landscape of cervical cancer and the growing clinical data regarding the use of immunotherapy. Checkpoint inhibitors are the best studied treatments, with encouraging phase II studies available in the definitive setting and recently published phase III data defining a new standard of care for patients with recurrent or metastatic disease. Vaccines and engineered T cells are generally in earlier phases of development but use unique mechanisms of immune activation. It is possible that combination of immunotherapy, with either conventional systemic therapy or multiple immunomodulatory agents, may provide further benefit. We also discuss possible synergies between immunotherapy and radiation therapy, which is frequently used in the management of cervical cancer. Ultimately, immunotherapy represents an emerging treatment option for patients with cervical cancer. It is an appropriate component of first-line treatment in the recurrent or metastatic setting and may soon be incorporated into definitive management of locally advanced disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
发嗲的高跟鞋完成签到,获得积分10
刚刚
传奇3应助希光光采纳,获得10
1秒前
Grayson完成签到,获得积分10
2秒前
夜曦完成签到 ,获得积分10
4秒前
4秒前
6秒前
黑眼圈完成签到,获得积分10
6秒前
香蕉觅云应助蚂蚁牙黑采纳,获得10
6秒前
好好好发布了新的文献求助10
7秒前
友好的半仙完成签到,获得积分10
8秒前
华仔应助suxin采纳,获得20
9秒前
科研通AI2S应助suxin采纳,获得10
9秒前
科研通AI2S应助suxin采纳,获得10
9秒前
DDTT完成签到,获得积分10
9秒前
那个笨笨完成签到,获得积分10
10秒前
12秒前
16秒前
佩吉的布丁完成签到 ,获得积分10
16秒前
独特的板凳完成签到,获得积分10
17秒前
djdh完成签到 ,获得积分10
17秒前
大个应助万物更始采纳,获得10
17秒前
jerry发布了新的文献求助10
18秒前
自由完成签到 ,获得积分10
18秒前
19秒前
21秒前
真三完成签到,获得积分10
22秒前
goofs完成签到,获得积分10
22秒前
殷超完成签到,获得积分10
23秒前
cc发布了新的文献求助10
23秒前
终于花开日完成签到 ,获得积分10
23秒前
阿水ovo完成签到 ,获得积分20
24秒前
谨慎天空完成签到 ,获得积分10
25秒前
25秒前
蚂蚁牙黑发布了新的文献求助10
26秒前
27秒前
微笑的井完成签到 ,获得积分10
28秒前
30秒前
lyy完成签到 ,获得积分10
33秒前
可耐的思远完成签到 ,获得积分10
33秒前
Ye发布了新的文献求助10
34秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139837
求助须知:如何正确求助?哪些是违规求助? 2790697
关于积分的说明 7796331
捐赠科研通 2447121
什么是DOI,文献DOI怎么找? 1301574
科研通“疑难数据库(出版商)”最低求助积分说明 626305
版权声明 601185